Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

BACKGROUND: Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic outbreak, the number of patients can exceed maximum capacity of intensive care units (ICUs), and, thus, these individuals of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Lancet Rheumatol
Huvudupphovsmän: Cavalli, Giulio, De Luca, Giacomo, Campochiaro, Corrado, Della-Torre, Emanuel, Ripa, Marco, Canetti, Diana, Oltolini, Chiara, Castiglioni, Barbara, Tassan Din, Chiara, Boffini, Nicola, Tomelleri, Alessandro, Farina, Nicola, Ruggeri, Annalisa, Rovere-Querini, Patrizia, Di Lucca, Giuseppe, Martinenghi, Sabina, Scotti, Raffaella, Tresoldi, Moreno, Ciceri, Fabio, Landoni, Giovanni, Zangrillo, Alberto, Scarpellini, Paolo, Dagna, Lorenzo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier Ltd. 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252085/
https://ncbi.nlm.nih.gov/pubmed/32501454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(20)30127-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk